Cefonicid
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a601206 |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C18H18N6O8S3 |
Molar mass | 542.56 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Cefonicide (or cefonicid) is a cephalosporin antibiotic.[1]
It has a density of 1.92g/cm3.
Synthesis
[edit]Injectable semi-synthetic cephalosporin antibiotic related to cefamandole, q.v.
![](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/Cefonicid_synthesis.svg/700px-Cefonicid_synthesis.svg.png)
Cefonicid is synthesized conveniently by nucleophilic displacement of the 3-acetoxy moiety of 1 with the appropriately substituted tetrazole thiole 2. The mandelic acid amide C-7 side chain is reminiscent of cefamandole.
See also
[edit]References
[edit]- ^ Saltiel E, Brogden RN (September 1986). "Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use". Drugs. 32 (3): 222–59. doi:10.2165/00003495-198632030-00002. PMID 3530703. S2CID 243051006.
- ^ DE 2611270, Berges, David Alan, "Cephalosporin-Derivate [Cephalosporin derivatives]", published 1976-09-30, assigned to SmithKline Corp.
- ^ D. A. Berges, U.S. patent 4,048,311 (1977 to Smith Kline).
- ^ U.S. patent 4,093,723, U.S. patent 4,159,373 (1978, 1979 both to Smith Kline).